# Developmental Funds

> **NIH NIH P30** · UNIVERSITY OF HAWAII AT MANOA · 2024 · $306,124

## Abstract

DEVELOPMENTAL FUNDS - ABSTRACT
Developmental Funds are requested to support five areas of high importance in accordance with the UHCC
strategic plan: Faculty Recruitment, Pilot Projects, Early Stage Clinical Investigators, Staff Investigators,
and Purchase of Peer-reviewed Shared Services to bring PDX services to the Center. The objective of the
University of Hawai‘i’s Cancer Center’s (UHCC) Developmental Funds is to strengthen cancer research
capabilities, foster scientific progress, improve patient outcomes, decrease cancer health disparities, and
advance our understanding of cancer. These objectives feed directly into UHCC’s mission to reduce the
burden of cancer in the State of Hawai‘i and the US Affiliated Pacific Islands. In alignment with the UHCC
strategic plan, we propose to use Developmental Funds to support four Aims: 1) Identify and recruit key faculty
with the leadership and research vision to expand our programs’ breadth and depth; 2) Identifying and funding
innovative pilot projects among UHCC Members to advance cancer research in key areas; 3) Encourage next-
generation translational scientists and physicians by jump-starting their research pathways; and 4) Strengthen
our commitment to bringing state-of-the-art treatment options by supporting preclinical services through
funding of a Staff Investigator and collaborating with an external PDX Shared Resource. By supporting these
areas, we will strengthen our existing Research Programs and achieve our stated vision to be a global leader
in cancer care, prevention, and education, significantly reducing the cancer burden in Hawai‘i and the Pacific.
The designated Developmental Funds will foster new collaborations, enhance translational and clinical science
capabilities for both CB and PSP Programs, and address the needs of our faculty members. Effective internal
and external advisory processes have been established to guide the allocation of Developmental Funds. Our
successful utilization of prior Developmental Funds is evidence of UHCC’s ability to leverage funding to make
transformative advances in basic, translational, and clinical research.

## Key facts

- **NIH application ID:** 10935916
- **Project number:** 2P30CA071789-23
- **Recipient organization:** UNIVERSITY OF HAWAII AT MANOA
- **Principal Investigator:** Naoto T. Ueno
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $306,124
- **Award type:** 2
- **Project period:** 1997-07-01 → 2029-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10935916

## Citation

> US National Institutes of Health, RePORTER application 10935916, Developmental Funds (2P30CA071789-23). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10935916. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*